Tripiomed 1 mg/500 mg/7.5 mg Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Primary uses of : Type 2 diabetes
|
Composition
|
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg) |
|
Potentially Unsafe With
|
Alcohol |
|
Side Effect
|
Common
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection. |
|
How to works
|
How Tripiomed Tablet SR works
Tripiomed 1 mg/500 mg/7.5 mg Tablet SR is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity. |
